Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Antidiabetic mechanism of ethanol extract of black rice bran on diabetic rats

Arifah Sri Wahyuni, Rima Munawaroh, Muhammad Da'i.




Abstract

Background: Black rice bran contains bioactive compounds; previous studies have shown the ethanol extract of black rice bran (EEBRB) can decrease levels in diabetic rats.

Aims and Objective: To elucidate the mechanism of antidiabetic effect of EEBRB.

Materials and Methods: This research was carried out by setting a few parameters for antidiabetic. The effects of inhibition of the enzyme alpha-glucosidase performed with in vitro studies using the extracted enzyme of intestines of mice. A total of 5 mL alpha-glucosidase enzyme was incubated for 5 min with EEBRB 1 mL with a serial concentration in phosphate buffer pH 7.2. Enzyme inhibitory effect was determined by measuring the concentration of formed glucose with Lane–Eynon method. The insulin level and glucose-lowering activity were determined on rats induced by alloxan 150 mg/kg and treated with EEBRB. Treated rats for 28 days were sacrificed and were prepared for histopathological observation of pancreas.

Result: EEBRB was able to inhibit the activity of the enzyme a-glucosidase on glucose with IC50 values of 121 ± 12.3 mg%. The EEBRB extract dose of 100 mg/kg was able to decrease blood sugar levels to 151 ± 38.58 mg/dL. The level of insulin in diabetic rats administered by EEBRB dose of 50, 100, and 200 mg/kg was obtained 6.52 ± 5.94, 11.5 ± 3.5, and 15.20 ± 9.5 ng/mL, respectively. Meanwhile, histopathological observations showed an improvement on the pancreatic beta cells.

Conclusion: Antidiabetic mechanism of EEBRB is associated with increased insulin levels because of regeneration of pancreatic beta cells in diabetic rats.

Key words: Black Rice Bran; Antidiabetic; Insulin Level; Pancreatic Beta Cells






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.